Biopharma Veterans Launch Boutique Agency Valence Communications
A team of physicians and scientists has unveiled Valence Communications, a New York-based agency designed to provide high-stakes advisory services to the biopharmaceutical sector. Led by CEO Matt Middleman, the firm enters the market with an established client roster, aiming to bridge the gap between complex clinical data and corporate strategy.
The founding team, which includes Co-Founders and EVPs Dan Perlmutter, Brittany Leigh, and Jason Braco, has structured the agency around a senior-led model. By embedding MD and PhD expertise directly into the communication process, the firm intends to move beyond traditional messaging to provide counsel that reflects the technical rigor of its clients' research. According to Middleman, the agency’s formation follows years of collaborative experience in high-pressure environments where the clarity of narrative often dictates market success.
Brittany Leigh emphasized that the agency’s focus remains on high-ambition projects regardless of a company's size. Whether positioning a biotech startup for investors or translating data for medical audiences, the firm’s approach relies on deep scientific literacy to build credibility. Valence operates across corporate, scientific, and medical communications, specifically targeting firms navigating critical milestones that require precise external influence.
Comments (0)
No comments yet. Be the first!